PRODUCT OVERVIEW & COMPOSITION
Brand / Manufacturer: Bioniche Pharma
Active Ingredient: Cabergoline (1 mg per tablet)
Pharmacological Class: Dopamine Receptor Agonist (Ergot Derivative)
Bioniche Pharma Cabergoline is a potent, long-acting dopamine $D_2$ receptor agonist engineered to suppress pituitary prolactin secretion. By directly stimulating dopamine receptors in the lactotroph cells of the anterior pituitary gland, it effectively reduces elevated serum prolactin concentration.
CLINICAL INDICATIONS
- Management of clinical hyperprolactinemia, including both idiopathic hyperprolactinemia and prolactin-secreting pituitary adenomas (micro- and macropolactinomas) using Bioniche Pharma formulations.
- Therapeutic regulation of endocrine imbalances associated with elevated circulating prolactin levels under Bioniche Pharma medical supervision.
DOSAGE & ADMINISTRATION
Dosing regimes for Bioniche Pharma Cabergoline must be individually determined and monitored under direct medical supervision. Treatment typically initiates at low threshold doses with gradual titration based on serum prolactin response and clinical tolerance.
ADVERSE EFFECTS
Clinical observations indicate that most reactions associated with Bioniche Pharma Cabergoline are dose-dependent and typically mild-to-moderate in intensity:
Gastrointestinal & Metabolic:
- Nausea, vomiting, dyspepsia, abdominal discomfort, flatulence, constipation, and xerostomia (dry mouth) reported during Bioniche Pharma therapy.
Neurological & Psychiatric:
- Cephalea (headache), dizziness, vertigo, somnolence, paresthesia (numbness or tingling sensation), nervousness, and depressive symptoms experienced by Bioniche Pharma patients.
Vascular & General Disturbances:
- Hot flashes, fatigue, and transient orthostatic fluctuations associated with Bioniche Pharma administration.
STORAGE & HANDLING
Store Bioniche Pharma products in a cool, dry environment shielded from direct light and moisture exposure. Keep strictly out of reach and sight of children.